Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
“With increasing global rates of Lyme disease, providing a new option for people to help protect themselves from the disease is more important than ever,” says Annaliesa Anderson, PhD, senior vice president and head of vaccine research & development at Pfizer.
While there haven’t been any reports of a cybersecurity threat, the vulnerability could allow an unauthorized user to take control of the medical device remotely, alter settings on the systems and even impact patient test results, according to the FDA.
The device is a novel self-operated prenatal home ultrasound solution that enables pregnant women to self-scan for remote clinical assessment by their healthcare provider when the device is combined with their smartphone.
“We know that premature babies have a better chance of survival if they get a high quality of care in the first month of birth,” Jong-Hoon Kim, associate professor at the Washington State University School of Engineering and Computer Science and a co-corresponding author on the study, said in a statement.
